Transarterial Chemoembolization Prior to Early Hepatocellular Carcinoma Laparoscopic Resection in Patients with Child A Cirrhosis

Codice QR

Transarterial Chemoembolization Prior to Early Hepatocellular Carcinoma Laparoscopic Resection in Patients with Child A Cirrhosis

None

Salvato in:

Dettagli Bibliografici
Autori principali:	Robles, Ricardo, Marín, Caridad, Parrilla, Pascual
Natura:	Elettronico Capitolo di libro
Lingua:	inglese
Pubblicazione:	IntechOpen 2011
Soggetti:	Health Sciences
Accesso online:	https://www.intechopen.com/chapters/21014
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
di: V. V. Borovik, et al.
Pubblicazione: (2022-09-01)

Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma
di: Xia Y, et al.
Pubblicazione: (2025-07-01)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
di: Chengxiang Guo, et al.
Pubblicazione: (2025-02-01)

RESULTS OF TRANSARTERIAL CHEMOEMBOLIZATION OF STOMACH CANCER METASTASES IN THE LIVER
di: D. T. Arybzhanov
Pubblicazione: (2017-02-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
di: B. I. Dolgushin, et al.
Pubblicazione: (2016-09-01)

Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
di: Wenjie Li, et al.
Pubblicazione: (2025-07-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
di: Hang Yuan, et al.
Pubblicazione: (2025-07-01)

Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
di: Lu J, et al.
Pubblicazione: (2025-05-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
di: O. Yu. Stukalova, et al.
Pubblicazione: (2019-12-01)

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
di: Yongfa Lei, et al.
Pubblicazione: (2025-07-01)

Liver function dynamics in advanced hepatocellular carcinoma receiving immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization
di: Chen-You Liu, et al.
Pubblicazione: (2025-06-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
di: Yao Yang, et al.
Pubblicazione: (2022-12-01)

Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma
di: Abimbola O. Williams, et al.
Pubblicazione: (2025-05-01)

Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer
di: Yuefeng Hu, et al.
Pubblicazione: (2025-12-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
di: S. A. Ivanov, et al.
Pubblicazione: (2023-03-01)

CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
di: A. I. Gritsaenko, et al.
Pubblicazione: (2017-01-01)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
di: Yuki Koga, et al.
Pubblicazione: (2018-08-01)

Transarterial Embolization of Intermediate Hepatocellular Carcinoma in Elderly Patients: Which Technique Should Be First-line?
di: Azzam Khankan, et al.
Pubblicazione: (2018-01-01)

Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection
di: Dongho Hyun
Pubblicazione: (2025-07-01)

Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
di: E. A. Zvezdkina, et al.
Pubblicazione: (2022-09-01)

Fluoroscopy-Guided Microwave Ablation after Transarterial Chemoembolization with Drug-coated Bead LUMI Radiopaque Beads
di: Aeed Saad AlAklabi, et al.
Pubblicazione: (2019-01-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
di: Zelong Liu, et al.
Pubblicazione: (2025-09-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
di: O. D. Olisov, et al.
Pubblicazione: (2018-09-01)

A case of resected hepatocellular carcinoma with gallbladder metastasis
di: Takaaki Hanazawa, et al.
Pubblicazione: (2021-06-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
di: Vladislav V. Petkau, et al.
Pubblicazione: (2024-03-01)

Laparoscopic partial liver resection for hepatocellular carcinoma arising from Fontan-associated liver disease: a case report
di: Miku Iwata, et al.
Pubblicazione: (2021-05-01)

Potential of magnetic-resonance tomography in differential diagnostics of liver cirrhosis and hepatocellular carcinoma
di: Ye. A. Kulyushina
Pubblicazione: (2009-10-01)

The role of transarterial chemoembolization with drug-eluting beads “Sphere-Spectrum” in the treatment of primary and recurrent tumors of the female reproductive system complicated by bleeding
di: E. A. Zvezdkina, et al.
Pubblicazione: (2023-08-01)

Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report
di: V. V. Makashova, et al.
Pubblicazione: (2023-04-01)

Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
di: D. A. Granov, et al.
Pubblicazione: (2021-01-01)

Endovascular Treatment for Iatrogenic Right External Iliac Artery Rupture during Transcatheter Chemoembolization of Hepatocellular Carcinoma: A Case Report
di: Min Jee Kim, et al.
Pubblicazione: (2025-07-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
di: Tao Huang, et al.
Pubblicazione: (2022-12-01)

The Use of Flow Cytometric DNA Ploidy Analysis of Liver Biopsies in Liver Cirrhosis and Hepatocellular Carcinoma
di: Tabll, Ashraf, et al.
Pubblicazione: (2011)

Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats
di: Gabriela Velasco-Loyden, et al.
Pubblicazione: (2017-02-01)

Laparoscopic Liver Resection
di: Cannon, Robert M., et al.
Pubblicazione: (2011)

Ischemic small bowel perforation caused by cholesterol crystal embolism following transcatheter arterial chemoembolization for recurrent hepatocellular carcinoma: a case report
di: Ryoga Hamura, et al.
Pubblicazione: (2021-02-01)

Hepatic resection for recurrent hepatocellular carcinoma during pregnancy: a case report
di: Takashi Maeda, et al.
Pubblicazione: (2020-09-01)

Combination of chemoembolization with hepatic resection and methods of local destruction in complex treatment of colorectal cancer
di: A. S. Zagainov, et al.
Pubblicazione: (2017-05-01)

Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
di: Hiroya Iida, et al.
Pubblicazione: (2020-03-01)

Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study
di: Bo Sun, et al.
Pubblicazione: (2025-07-01)